Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up

RAD51C-related cancer predisposition

MONDO:0700273

Hereditary cancer predisposition due to variation(s) in the RAD51C gene. Pathogenic germline variation in RAD51C confers an autosomal dominant predisposition to tumor formation at multiple primary sites, including ovarian cancer, triple negative breast cancer and ER negative breast cancer.

41 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (618) Hereditary disease (172) Inherited disease susceptibility (69) Hereditary neoplastic syndrome (57) Syndromic disease (24) Human disease (14) Neoplastic disease or syndrome (6) Disease susceptibility (3) Disease of genetic or genomic mechanism (2) Cancer or benign tumor (0)
Trials to join now! 21 Not yet recruiting 2 Not yet finished but already full! 12 Completed 5 Terminated 1
Sort by
  • Cancer drug niraparib tested before prostate surgery – early trial stopped

    Disease control Terminated

    This phase II trial tested the drug niraparib (Zejula) in 11 men with high-risk prostate cancer that had not spread. All men had specific DNA repair gene mutations. They took niraparib before having their prostate removed surgically. The goal was to see if the drug could eliminat…

    Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control

    Last updated Jun 27, 2026 12:33 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space